Humana (NYSE:HUM) Sets New 12-Month High – Here’s What Happened

Humana Inc. (NYSE:HUM) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $381.98 and last traded at $384.2350, with a volume of 114015 shares changing hands. The stock had previously closed at $376.00.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on HUM shares. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Needham & Company LLC began coverage on Humana in a report on Wednesday, May 20th. They issued a “buy” rating for the company. Oppenheimer raised Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Bank of America raised their price objective on Humana from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Wednesday. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $260.00 price objective on shares of Humana in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $293.09.

Humana Trading Up 2.2%

The business’s fifty day moving average is $303.11 and its 200-day moving average is $245.73. The stock has a market capitalization of $46.13 billion, a PE ratio of 41.09, a P/E/G ratio of 2.19 and a beta of 0.76. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts anticipate that Humana Inc. will post 9.04 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is presently 37.86%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Revolve Wealth Partners LLC acquired a new stake in Humana during the fourth quarter worth about $202,000. Woodline Partners LP lifted its stake in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after purchasing an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in shares of Humana by 53.7% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the period. Cresset Asset Management LLC grew its holdings in shares of Humana by 10.3% during the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after purchasing an additional 222 shares during the period. Finally, WINTON GROUP Ltd increased its position in Humana by 58.5% during the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.